DexCom, Inc. (DXCM)
70.70
-2.20
(-3.02%)
USD |
NASDAQ |
Mar 05, 16:00
70.70
0.00 (0.00%)
After-Hours: 20:00
DexCom Free Cash Flow : 1.077B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioLife Solutions, Inc. | 10.64M |
| Abbott Laboratories | 7.395B |
| Insulet Corp. | 349.90M |
| Krystal Biotech, Inc. | 188.91M |
| Boston Scientific Corp. | 3.658B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 294.00M |
| Cash from Investing (Quarterly) | 306.60M |
| Cash from Financing (Quarterly) | -1.522B |
| Free Cash Flow Per Share (Quarterly) | 0.4816 |
| Free Cash Flow to Equity (Quarterly) | 1.378B |
| Free Cash Flow to Firm (Quarterly) | 195.40M |
| Free Cash Flow Yield | 3.76% |